Clinical Trial VICCREACH1447
Retinoblastoma Survivor Study (RBSS)
- Protocol No. VICCREACH1447
- Open Date: 04/16/2014
- Staging: N/A
- Age Group: Children
- Scope: Local
- Objective: Determine the cumulative incidence, prevalence and spectrum of targeted long-term health related outcomes in the cohort.
- Disease Sites: Retinoblastoma (Pediatrics)
- Therapies: Supportive Care
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- National Clinical Trial ID: NCTNA
- Secondary Protocol No: Not Specified
Not provided. Please call for more information.